Correlation Between Alphatec Holdings and Predictive Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alphatec Holdings and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphatec Holdings and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphatec Holdings and Predictive Oncology, you can compare the effects of market volatilities on Alphatec Holdings and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphatec Holdings with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphatec Holdings and Predictive Oncology.

Diversification Opportunities for Alphatec Holdings and Predictive Oncology

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Alphatec and Predictive is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Alphatec Holdings and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Alphatec Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphatec Holdings are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Alphatec Holdings i.e., Alphatec Holdings and Predictive Oncology go up and down completely randomly.

Pair Corralation between Alphatec Holdings and Predictive Oncology

Given the investment horizon of 90 days Alphatec Holdings is expected to generate 0.69 times more return on investment than Predictive Oncology. However, Alphatec Holdings is 1.46 times less risky than Predictive Oncology. It trades about -0.01 of its potential returns per unit of risk. Predictive Oncology is currently generating about -0.11 per unit of risk. If you would invest  1,113  in Alphatec Holdings on April 28, 2025 and sell it today you would lose (31.00) from holding Alphatec Holdings or give up 2.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Alphatec Holdings  vs.  Predictive Oncology

 Performance 
       Timeline  
Alphatec Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Alphatec Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Alphatec Holdings is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Predictive Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Alphatec Holdings and Predictive Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alphatec Holdings and Predictive Oncology

The main advantage of trading using opposite Alphatec Holdings and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphatec Holdings position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.
The idea behind Alphatec Holdings and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine